Published in Eur J Neurosci on January 01, 2001
The corticostriatal pathway in Huntington's disease. Prog Neurobiol (2006) 1.99
Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models. Nat Commun (2016) 1.42
Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol Neurodegener (2007) 1.39
Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron (2008) 1.38
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx (2005) 1.33
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat (2010) 1.06
Dopamine and glutamate in Huntington's disease: A balancing act. CNS Neurosci Ther (2010) 1.03
Role of cerebral cortex in the neuropathology of Huntington's disease. Front Neural Circuits (2013) 1.02
Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. Basal Ganglia (2012) 1.02
Changes in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington disease. Proc Natl Acad Sci U S A (2011) 0.93
Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease. Chem Biol (2013) 0.90
Expression of expanded polyglutamine targets profilin for degradation and alters actin dynamics. Neurobiol Dis (2008) 0.89
Treatment of Huntington's disease. Neurotherapeutics (2014) 0.82
Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease. J Neurosci (2015) 0.78
Effect of Jian-Pi-Zhi-Dong Decoction on striatal glutamate and γ-aminobutyric acid levels detected using microdialysis in a rat model of Tourette syndrome. Neuropsychiatr Dis Treat (2016) 0.77
Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease. Antioxid Redox Signal (2013) 0.75
Intracerebroventricular Administration of Amyloid β-protein Oligomers Selectively Increases Dorsal Hippocampal Dialysate Glutamate Levels in the Awake Rat. Sensors (Basel) (2008) 0.75
Corticostriatal Dysfunction in Huntington's Disease: The Basics. Front Hum Neurosci (2016) 0.75
Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2017) 0.75
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci (1999) 3.06
Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev (1994) 2.34
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med (1992) 2.01
Glomerular size and charge selectivity in the rat as revealed by FITC-ficoll and albumin. Am J Physiol Renal Physiol (2000) 1.89
Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules. Am J Physiol Renal Physiol (2001) 1.73
Weight loss in Huntington disease increases with higher CAG repeat number. Neurology (2008) 1.66
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat Med (1995) 1.61
Site-directed mutagenesis in photosystem II of the cyanobacterium Synechocystis sp. PCC 6803: Donor D is a tyrosine residue in the D2 protein. Proc Natl Acad Sci U S A (1988) 1.57
High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neurol (2006) 1.53
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia (2008) 1.50
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Bayesian estimation of synaptic physiology from the spectral responses of neural masses. Neuroimage (2008) 1.46
Extensive changes in the transcriptional profile of human adipose tissue including genes involved in oxidative phosphorylation after a 6-month exercise intervention. Acta Physiol (Oxf) (2014) 1.45
Functional integration of cortical grafts placed in brain infarcts of rats. Ann Neurol (1993) 1.43
Low IL-8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels. Acta Psychiatr Scand (2014) 1.43
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet (2001) 1.42
The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat. Brain (1986) 1.40
Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer (2000) 1.36
Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia (2009) 1.33
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci U S A (1999) 1.30
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol (1997) 1.29
A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ (2011) 1.27
Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature (1990) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience (2005) 1.22
Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int (2001) 1.21
Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery (1996) 1.19
The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci (1993) 1.18
CSF biomarkers predict a more malignant outcome in Alzheimer disease. Neurology (2010) 1.18
The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology (1999) 1.17
CAPD in patients with autosomal dominant polycystic kidney disease. Perit Dial Int (1999) 1.16
Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism. Pain (1997) 1.16
Synaptic dysfunction in Huntington's disease: a new perspective. Cell Mol Life Sci (2005) 1.16
Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant (2000) 1.15
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain (1999) 1.14
A gel-membrane model of glomerular charge and size selectivity in series. Am J Physiol Renal Physiol (2001) 1.14
Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol (1992) 1.13
The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett (1998) 1.12
Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res (1986) 1.11
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur J Neurosci (2001) 1.10
Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol (2001) 1.09
Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci (1998) 1.08
Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice. Neurobiol Dis (2002) 1.06
Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med (1999) 1.06
Vaccinia Gangrenosa with normal humoral antibodies. A case possibly due to deficient cellular immunity treated with N-methylisatin beta-thiosemicarbazone (Compound 33T57, Marboran). Acta Paediatr Scand (1966) 1.05
High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Renal Physiol (2010) 1.04
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp Brain Res (1988) 1.04
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04
The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol (1996) 1.04
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis (2006) 1.03
Orosomucoid as one of the serum components contributing to normal capillary permselectivity in rat skeletal muscle. Acta Physiol Scand (1987) 1.03
Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry (1997) 1.02
Familial ataxic diplegia with deficient cellular immunity. A new clinical entity. Acta Paediatr Scand (1970) 1.02
The executioners sing a new song: killer caspases activate microglia. Cell Death Differ (2011) 1.02
Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am J Physiol (1999) 1.01
Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke (1993) 1.00
Flash-photolysis studies of the electron transfer from genetically modified spinach plastocyanin to photosystem I. FEBS Lett (1991) 1.00
Crystal structure of spinach plastocyanin at 1.7 A resolution. Protein Sci (1998) 0.99
Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature (1984) 0.99
Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes. Diabetologia (2012) 0.99
The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neuroreport (1997) 0.99
Recent advances on the pathogenesis of Huntington's disease. Exp Neurol (1999) 0.98
Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience (1994) 0.97
Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience (1985) 0.97
Reactivity of cytochromes c and f with mutant forms of spinach plastocyanin. Biochim Biophys Acta (1992) 0.97
Brain injury activates microglia that induce neural stem cell proliferation ex vivo and promote differentiation of neurosphere-derived cells into neurons and oligodendrocytes. Neuroscience (2010) 0.96
The future of cell therapies and brain repair: Parkinson's disease leads the way. Neuropathol Appl Neurobiol (2014) 0.96
Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem (2003) 0.96
Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol (1992) 0.96
Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp Brain Res (1995) 0.96
In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron (1990) 0.96
Evidence for a selective prefrontal cortical GABA(B) receptor-mediated inhibition of glutamate release in the ventral tegmental area: a dual probe microdialysis study in the awake rat. Neuroscience (2005) 0.96
Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res (2000) 0.95
The Origin of the Multiline and g = 4.1 Electron Paramagnetic Resonance Signals from the Oxygen-Evolving System of Photosystem II. Biophys J (1987) 0.95
Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Res (1997) 0.95
Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci (1996) 0.95
The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J Neurosci (1998) 0.95
Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci U S A (1994) 0.95
Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome. Am J Physiol Renal Physiol (2006) 0.94
A membrane-bound monoheme cytochrome c551 of a novel type is the immediate electron donor to P840 of the Chlorobium vibrioforme photosynthetic reaction center complex. J Biol Chem (1992) 0.94
Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia (2006) 0.94
Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations. Acta Physiol Scand (1987) 0.94
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease? Int J Geriatr Psychiatry (2009) 0.93
trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. J Neurochem (2000) 0.93
Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp Brain Res (1993) 0.93
Tryptophan load tests and pyridoxal-5-phosphate levels in epileptic children. II. Cryptogenic epilepsy. Acta Paediatr Scand (1966) 0.93
Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res (1994) 0.92
Computer simulations of peritoneal fluid transport in CAPD. Kidney Int (1991) 0.92
A common variant upstream of the PAX6 gene influences islet function in man. Diabetologia (2011) 0.92
The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett (1996) 0.91
Phenotypic development of the human embryonic striatal primordium: a study of cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience (1996) 0.91
Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J Comp Neurol (1992) 0.91
A quantitative analysis of the glomerular charge barrier in the rat. Am J Physiol Renal Physiol (2001) 0.90
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine. Eur J Neurosci (2001) 0.90